The Drug Eluting Technology Show is a full educational program featuring a panel of experts, Key opinion leaders, aiming at raising awareness about the use of drug-eluting technologies, which have emerged as effective and safe options for treating PAD, especially when compared to POBA or bare metal stents.
Program Agenda :
1. Paclitaxel Safety
2. DES & DCB Benefits Over BMS and POBA
3. By-Pass verse DET and amputation rates on PTX leverage True PTX and DETECT
4. Paclitaxel vs. Limus
5. The Restenosis Challenge
6. Managing lesion types: DES Vs DCB optimal strategy?